Health & bio
ATTAIN-1 Phase 3: Up to 12-Pound Weight Loss at Highest Dose
ATTAIN-1 Phase 3 results showed 12-pound average weight loss (12.4%) at the highest dose, compared to 16.6% with oral semaglutide.
Primary sources · 1
ATTAIN-1 Phase 3 results showed 12-pound average weight loss (12.4%) at the highest dose, compared to 16.6% with oral semaglutide.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.